S&P 500   2,995.35 (-0.01%)
DOW   27,019.84 (-0.02%)
QQQ   193.28 (-0.12%)
AAPL   234.54 (-0.33%)
FB   188.83 (-0.03%)
GOOGL   1,251.80 (+0.77%)
AMZN   1,785.35 (+1.02%)
CGC   19.76 (-1.69%)
NVDA   197.54 (+0.60%)
MU   46.18 (-0.58%)
GE   9.01 (+1.35%)
TSLA   261.59 (+1.43%)
BAC   30.40 (+2.25%)
GILD   65.66 (+0.55%)
DIS   130.71 (+0.73%)
S&P 500   2,995.35 (-0.01%)
DOW   27,019.84 (-0.02%)
QQQ   193.28 (-0.12%)
AAPL   234.54 (-0.33%)
FB   188.83 (-0.03%)
GOOGL   1,251.80 (+0.77%)
AMZN   1,785.35 (+1.02%)
CGC   19.76 (-1.69%)
NVDA   197.54 (+0.60%)
MU   46.18 (-0.58%)
GE   9.01 (+1.35%)
TSLA   261.59 (+1.43%)
BAC   30.40 (+2.25%)
GILD   65.66 (+0.55%)
DIS   130.71 (+0.73%)
Log in

NanoVibronix Stock Price, News & Analysis (NASDAQ:NAOV)

$2.99
0.00 (0.00 %)
(As of 10/16/2019 11:19 AM ET)
Today's Range
$2.99
Now: $2.99
$2.99
50-Day Range
$2.10
MA: $2.60
$3.00
52-Week Range
$1.96
Now: $2.99
$4.50
VolumeN/A
Average Volume8,981 shs
Market Capitalization$13.25 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.52
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products in the United States, Israel, Europe, India, and internationally through distributor agreements. NanoVibronix, Inc. was founded in 2003 and is based in Elmsford, New York.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NAOV
CUSIPN/A
Phone914-233-3004

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$320,000.00
Book Value$0.12 per share

Profitability

Net Income$-4,150,000.00
Net Margins-1,406.00%

Miscellaneous

Employees10
Market Cap$13.25 million
Next Earnings Date11/13/2019 (Estimated)
OptionableNot Optionable

Receive NAOV News and Ratings via Email

Sign-up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter.


NanoVibronix (NASDAQ:NAOV) Frequently Asked Questions

What is NanoVibronix's stock symbol?

NanoVibronix trades on the NASDAQ under the ticker symbol "NAOV."

How were NanoVibronix's earnings last quarter?

NanoVibronix Inc (NASDAQ:NAOV) released its quarterly earnings results on Wednesday, August, 14th. The company reported ($0.16) earnings per share for the quarter, beating analysts' consensus estimates of ($0.20) by $0.04. The business had revenue of $0.26 million for the quarter, compared to the consensus estimate of $0.09 million. NanoVibronix had a negative net margin of 1,406.00% and a negative return on equity of 766.68%. View NanoVibronix's Earnings History.

When is NanoVibronix's next earnings date?

NanoVibronix is scheduled to release their next quarterly earnings announcement on Wednesday, November 13th 2019. View Earnings Estimates for NanoVibronix.

What is the consensus analysts' recommendation for NanoVibronix?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NanoVibronix in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for NanoVibronix.

Has NanoVibronix been receiving favorable news coverage?

News headlines about NAOV stock have been trending neutral recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. NanoVibronix earned a coverage optimism score of 0.4 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for NanoVibronix.

Are investors shorting NanoVibronix?

NanoVibronix saw a increase in short interest in September. As of September 30th, there was short interest totalling 30,000 shares, an increase of 25.0% from the August 30th total of 24,000 shares. Based on an average daily volume of 14,100 shares, the days-to-cover ratio is presently 2.1 days. Approximately 0.9% of the company's stock are short sold. View NanoVibronix's Current Options Chain.

Who are some of NanoVibronix's key competitors?

What other stocks do shareholders of NanoVibronix own?

Who are NanoVibronix's key executives?

NanoVibronix's management team includes the folowing people:
  • Mr. Brian M. Murphy, CEO & Director (Age 62)
  • Dr. William Stern, Pres (Age 77)
  • Mr. Stephen R. Brown CPA, Chief Financial Officer (Age 63)
  • Dr. Harold Jacob, Chief Medical Officer & Director (Age 65)
  • Mr. Amir Rippel, VP of Marketing

How do I buy shares of NanoVibronix?

Shares of NAOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is NanoVibronix's stock price today?

One share of NAOV stock can currently be purchased for approximately $2.99.

How big of a company is NanoVibronix?

NanoVibronix has a market capitalization of $13.25 million and generates $320,000.00 in revenue each year. The company earns $-4,150,000.00 in net income (profit) each year or ($0.64) on an earnings per share basis. NanoVibronix employs 10 workers across the globe.View Additional Information About NanoVibronix.

What is NanoVibronix's official website?

The official website for NanoVibronix is http://www.nanovibronix.com/.

How can I contact NanoVibronix?

NanoVibronix's mailing address is 525 Executive Blvd, Elmsford NY, 10523. The company can be reached via phone at 914-233-3004 or via email at [email protected]


MarketBeat Community Rating for NanoVibronix (NASDAQ NAOV)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  65 (Vote Outperform)
Underperform Votes:  96 (Vote Underperform)
Total Votes:  161
MarketBeat's community ratings are surveys of what our community members think about NanoVibronix and other stocks. Vote "Outperform" if you believe NAOV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NAOV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/16/2019 by MarketBeat.com Staff

Featured Article: What are earnings reports?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel